Tectonic Therapeutic (TECX) Current Deferred Revenue (2019 - 2022)
Tectonic Therapeutic (TECX) posted quarterly Current Deferred Revenue of $51000.0 for Q3 2022, down 80.83% year-over-year from $266000.0 in Q3 2021, and down 72.13% quarter-over-quarter from $183000.0 in Q2 2022.
Tectonic Therapeutic (TECX) Current Deferred Revenue (2019 - 2022) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Current Deferred Revenue for 4 consecutive years, with $51000.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Current Deferred Revenue fell 80.83% year-over-year to $51000.0; the TTM figure through Sep 2022 stood at $51000.0 (down 80.83% YoY), while the FY2021 annual figure was $262000.0, up 9.62% from the prior year.
- Current Deferred Revenue eased to $51000.0 in Q3 2022 per TECX's latest filing, from $183000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $266000.0 in Q3 2021 and bottomed at $51000.0 in Q3 2022.
- Historically, Current Deferred Revenue has averaged $215200.0 across 4 years, with a median of $227500.0 in 2020.
- Annual changes were most pronounced in 2021 — Current Deferred Revenue grew 23.15% — and 2022, when it plunged 80.83%.
- Tectonic Therapeutic's Current Deferred Revenue stood at $214000.0 in 2019, then increased by 11.68% to $239000.0 in 2020, then grew by 9.62% to $262000.0 in 2021, then sank by 80.53% to $51000.0 in 2022.
- Business Quant data shows TECX's Current Deferred Revenue at $51000.0 in Q3 2022, $183000.0 in Q2 2022, and $214000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 51,000.00 |
| Jun 30, 2022 | 183,000.00 |
| Mar 31, 2022 | 214,000.00 |
| Dec 31, 2021 | 262,000.00 |
| Sep 30, 2021 | 266,000.00 |
| Jun 30, 2021 | 259,000.00 |
| Mar 31, 2021 | 248,000.00 |
| Dec 31, 2020 | 239,000.00 |
| Sep 30, 2020 | 216,000.00 |
| Dec 31, 2019 | 214,000.00 |